Article Text

PDF

Syndecan-4 regulates cartilage degradation in osteoarthritis
  1. F Echtermeyer,
  2. J Betrand,
  3. I Meinecke,
  4. K Neugebauer,
  5. C Herzog,
  6. Y J Lee,
  7. Y W Song,
  8. R Dreier,
  9. T Pap
  1. Hannover Medical School, Hannover, Germany

Statistics from Altmetric.com

Cartilage breakdown by loss of proteoglycans is one of the hallmarks of osteoarthritis (OA). The aggrecanase ADAMTS-5 has been shown to be responsible for proteoglycan loss in arthritic mouse cartilage. However, the mechanisms that lead to ADAMTS-5 activation during cartilage remodelling are poorly understood.

Based on recent data that have implicated transmembrane heparan sulfate proteoglycans in matrix turnover, we analysed the relationship between syndecan-4 and ADAMTS-5 in osteoarthritic cartilage and in different animal models of OA. To study syndecan-4 in OA, we surgically achieved joint instability in syndecan-4-/- mice (Sdc4–/–), wild-type controls and wild-type animals treated with a Sdc4-specific antibody. We determined the severity of the induced cartilage damage by Mankin scores, proteoglycan loss and collagen type X staining. Staining for syndecan-4 and ADAMTS generated aggrecan neo-epitopes and matrix metalloproteinase 3 (MMP-3) was performed in cartilage sections of these mice. For in vitro studies, femur cartilage caps isolated from 3–weeks-old wild-type and Sdc4–/– mice were used to analyse interleukin 1 (IL1)-induced proteoglycan loss (dimethylmethylene blue assay), ADAMTS activity (aggrecan-neo-epitope ELISA), gene expression (real-time PCR) and mitogen-activated protein kinase (MAPK) activation (immunoblot). Interaction of Sdc4 and ADMATS-5 was determined by co-immunoprecipitation from arthritic chondrocytes.

There was a strong upregulation of syndecan-4 in human and rodent OA cartilage. Analysis of osteoarthritic changes in mice revealed a correlation between collagen type X and Sdc4 staining in dedifferentiated hypertrophic chondrocytes. Sdc4–/– OA mice had a significant reduction in Mankin scores and a reduction in the loss of proteoglycans. This was accompanied by significantly reduced staining for ADAMTS-generated aggrecan neo-epitopes and an increase in MMP-3 staining in Sdc4–/– mice. ADAMTS-5 expression was upregulated by IL1 equally in wild-type and Sdc4–/– femur cap cartilage; however, MMP-3 expression was lower in Sdc4–/– OA cartilage. IL1-induced proteoglycan loss was significantly reduced in Sdc4–/– cartilage. Intra-articular injection of Sdc4-blocking antibodies prevented OA-induced cartilage damage, proteoglycan loss and MMP-3 expression to the same extent as in Sdc4–/– mice. In vitro blocking syndecan-4 inhibited IL1-induced proteoglycan loss, ADAMTS protease activity and extracellular signal-regulated kinase 1 and 2 (ERK 1/2) phosphorylation. Sdc4 directly binds ADAMTS-5 and regulates ADAMTS-5 activation through MMP-3 expression, as an MMP inhibitor reduced ADAMTS-mediated aggrecan cleavage.

Our data show for the first time that syndecan-4 controls early cartilage damage by hypertrophic OA chondrocytes through activation of ADAMTS-mediated cleavage of aggrecan. Inhibition of syndecan-4 may therefore constitute a promising strategy to interfere with osteoarthritic cartilage damage.

View Abstract

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.